|
04/03/2007
Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Dose Escalation Trial with TovaxinTM for Multiple Sclerosis
03/20/2007
Houston Technology Center Announces $2 Million Award to PLx Pharma Inc., $794,520 Award to Molecular LogiX Inc. by the Texas Emerging Technology Fund
03/19/2007
Opexa Reports Year End 2006 Financial Results
03/01/2007
Kryptiq Applauds Steps to Improve Healthcare Efficiency and Patient–Centered Care
02/14/2007
Opexa Therapeutics Launches Tovaxin™ Clinical Trial Website for Multiple Sclerosis
12/07/2006
Kryptiq Recognized as an Oregon Most Admired Company Company Honored as One of the State’s Top Ten Technology Companies
11/13/2006
Opexa Reports Third Quarter Financial Results
11/06/2006
Opexa Begins Dosing Patients in Phase IIb Trial of Tovaxin™ for Multiple Sclerosis
10/31/2006
Opexa Therapeutics to Present at Rodman & Renshaw Eighth Annual Healthcare Conference
10/23/2006
Opexa Therapeutics to Present at C.E. Unterberg, Towbin Life Sciences Investor Conference
10/04/2006
EnVivo Secures $24 Million in Series C Financing
09/19/2006
Sapphire Therapeutics, Inc. Licenses Ghrelin Mimetic From Novo Nordisk
Ipamorelin to Enter Phase II for Postoperative Ileus
09/18/2006
Opexa Commences Phase IIb Multiple Sclerosis Study
Reports Positive Phase I/II Data
Provides Update on Preclinical Progress
09/15/2006
Opexa Therapeutics Inc. (OPXA) CEO to Ring The NASDAQ Stock Market Closing Bell
09/14/2006
Oregon Investment Fund Selects Kryptiq for First Direct Investment
Portland-based healthcare company completes C round from current investors and Oregon Investment Fund
09/01/2006
Opexa Shares to Trade on NASDAQ Global Market
08/25/2006
Sapphire Therapeutics, Inc. Expands Drug Development Team; New CEO, Board Appointment
08/14/2006
Opexa Reports Second Quarter Financial Results
06/26/2006
Scientists at Opexa Therapeutics Generate Human Insulin-Producing Islet Clusters in Culture from Monocyte-Derived Stem Cells
06/19/2006
PharmaFrontiers Changes Name to Opexa Therapeutics; New Ticker Symbol is OPXA
06/16/2006
PharmaFrontiers Appoints Michael Richman to Board of Directors
06/06/2006
PharmaFrontiers to Present at Marcus Evans Conference, "Facing Stem Cell Research Challenges"
05/23/2006
EnVivo Expands Management Team as Company Prepares First Drugs for Clinical Trials
05/15/2006
PharmaFrontiers Reports First Quarter 2006 Results
05/03/2006
PharmaFrontiers Names Lynne Hohlfeld Vice President of Finance
05/01/2006
PerkinElmer Acquires Spectral Genomics, Inc. Strengthening Capabilities in Screening and Diagnostics; Leading-Edge Molecular Karyotyping Technology Expected to Drive Advances in Prenatal and Neonatal Research and Disease Detection
04/17/2006
PharmaFrontiers Completes $23 Million Financing to Advance Therapeutics; Plans Reverse Stock Split
04/17/2006
PharmaFrontiers Appoints Gregory Bailey, M.D. and Scott Seaman, CPA, to Board of Directors
03/31/2006
PharmaFrontiers Reports Year End 2005 Financial Results
03/28/2006
PharmaFrontiers to Present Data on Adult Human T-Cell and Stem Cell Technologies at the International Society for Cellular Therapy Annual Meeting
03/22/2006
PharmaFrontiers to Present Tovaxin(TM) Research at Consortium of Multiple Sclerosis Centers' Annual Meeting
03/03/2006
Julia Wren presents at 2006 AUTM Annual Meeting
03/02/2006
Onyx and Kryptiq Join Forces to Improve Healthcare Provider Management
Integration of systems increases efficiencies and controls legal risks through improved management of the healthcare provider life cycle
03/02/2006
Dr. Buz Brown leads panel at 2006 AUTM Annual Meeting
02/23/2006
Kryptiq CEO Presents Testimony to Subcommittee of U.S. House of Representatives
Machuca Recommends Prioritization of Organic RHIO Expansion While Limiting Additional Spending on Centralized or Federated Models
02/13/2006
Providence Medical Group Releases Results of Diabetes Study
Kryptiq’s CareManager™ Diabetes Module Leads to a 58 percent Improvement in the Number of Patients with Diabetes who Achieved Control of their Cholesterol and Blood Pressure Levels
02/06/2006
MedcomSoft and Kryptiq Announce Technology Partnership – Integrated Solution to be Showcased @ HIMSS
Users of MedcomSoft Record™ 2006 will now have access to integrated patient portal and secure messaging integrated with their EMR
02/02/2006
Kryptiq Releases Coronary Heart Disease Module
Software Helps Physicians Win the Battle Against Leading Cause of Death in America
01/31/2006
Kryptiq Customer Base Grows Over 100 Percent in 2005
Award-Winning Connectivity Solutions Solve Key Healthcare Challenges Today
01/17/2006
Sapphire Therapeutics, Inc. Appoints New Director and Scientific Advisory Board to Support Oncologic and Metabolic Pipeline Development
01/17/2006
PharmaFrontiers Acquires Autologous T Cell Vaccine Rights for Rheumatoid Arthritis
01/06/2006
Sapphire Therapeutics, Inc. Builds Drug Development Team Through New Hires and Promotion
01/05/2006
Physicians in Florida Connect Pay-for-Performance to Quality Healthcare
Melbourne Internal Medicine Associates Implements Kryptiq CareManager™ to Create Disease Management Benchmarks
12/15/2005
Sapphire Therapeutics, Inc.’s Oral Ghrelin Mimetic
Shows Potential for Treating Cancer Anorexia/Cachexia
12/14/2005
Kryptiq Honored by GE Centricity® Users With 2005 Achievements and Innovations Award
Kryptiq’s ClinicalMessenger™ 3.0 Wins Best Vendor Innovation
12/01/2005
PharmaFrontiers Appoints Mathilda Mandel to Clinical Advisory Board
11/30/2005
[KUHF] New Grant for Nano-Technology Cancer Research (by Laurie Johnson)
11/23/2005
Bacteria firm to grow in Athens (Published in the Athens Banner-Herald on 11.23.2005)
11/15/2005
PharmaFrontiers Shareholders Approve Increase in Authorized Shares at Special Meeting
11/15/2005
PharmaFrontiers Reports Third Quarter 2005 Financial Results; Provides Update on Research & Development Activities
11/07/2005
Providence Health Plans Will Speak at AHIP Business Forum
Session Reveals Key Steps to Successful Health Plan Contract Management Implementation with Kryptiq Guardian Contract Manager
10/31/2005
PharmaFrontiers Tovaxin(TM) Phase IIb Multiple Sclerosis Clinical Trial Protocol Accepted by FDA
10/26/2005
PharmaFrontiers Corp. Elects Interim Chairman
10/18/2005
Wallstreet Reporter Interviews Sapphire Therapeutics
10/17/2005
Kryptiq CEO to Speak at California Association of Health Plans
Expert Panel to Discuss Real Life Applications of Electronic Health Records to Facilitate Collaboration between Health Plans, Providers, and Patients
10/05/2005
Rejuvenon Corporation. changes name to Sapphire Therapeutics;
Closes on second tranche of Series B financing
10/03/2005
PharmaFrontiers Presents Positive Tovaxin(TM) Research at International Multiple Sclerosis Meeting
09/29/2005
Fairway Medical Technologies Receives $2.9 Million National Cancer Institute Nanotechnology Grant for Early Breast Cancer Detection Technology
09/29/2005
[Houston Business Journal] Fairway gets grant for development of breast cancer technology
09/08/2005
Physicians Take Charge of Health for Patients with Chronic Diseases
DecaturMemorial Hospital Deploys New CareManager™ Surveillance System From Kryptiq to Better Serve Chronically Ill Patients
08/16/2005
PharmaFrontiers Reports Second Quarter 2005 Financial Results; Provides Research Update
08/10/2005
PharmaFrontiers to Present Tovaxin(TM) Research at International Multiple Sclerosis Meeting
07/25/2005
BCM Technologies president named to board of bioscience accelerator
07/20/2005
Rejuvenon’s RC-8800 for Prostate Cancer Enters Human Testing
RC-1291 Ghrelin Mimetic Starts Phase II in Cachexia
07/01/2005
PHARMAFRONTIERS CORP Files SEC form 8-K, Sale of Equity
06/27/2005
EnVivo Appoints Kees Been as Chief Executive Officer
06/20/2005
PharmaFrontiers Completes $5.08 MM Financing
06/14/2005
Biopharma Agennix To Seek Up To $50M For Phase III Trials
06/13/2005
Agennix's Topical Talactoferrin Improved Healing of Diabetic Ulcers
06/08/2005
PharmaFrontiers Presented Preliminary Tovaxin Clinical Plans at Multiple Sclerosis Centers Meeting
06/03/2005
PharmaFrontiers Announces Positive Interim Results of Two Phase I/II Clinical Trials for Multiple Sclerosis
05/24/2005
Kryptiq Connectivity Summit Fuels Healthcare Transformation Momentum
CEO Directs Industry to Create National Health Information Network One Physician Office, One Workflow at a Time
05/19/2005
INHS Selects Kryptiq to Connect Regional Health Information System
Kryptiq ClinicalMessenger Facilitates Fluid Exchange of Health Information
05/17/2005
PharmaFrontiers Adds Three Members to Its Scientific Advisory Board
05/17/2005
Agennix's Oral Talactoferrin Improved Response Rates, Time to Progression and Duration of Response When Combined with First-Line Chemotherapy in Advanced Non-Small Cell Lung Cancer
Presented at ASCO
05/16/2005
Memorial Family Care Deploys Kryptiq ClinicalMessenger 3.0
New Software Fosters Efficient Health Information Exchange in Communities to Inform Clinical Practices and Interconnect Clinicians
05/03/2005
PharmaFrontiers Selects INC Research as Development Partner for its Novel Multiple Sclerosis Therapy
04/29/2005
ADViSYS: Electroporation, a step closer to efficient vaccine delivery
04/26/2005
PharmaFrontiers Announces Dr. Eliezer Huberman to Chair Scientific Advisory Board
04/19/2005
Agennix's Oral Talactoferrin Substantially Improved Response Rates When Combined with First-Line Chemotherapy in Advanced Non-Small Cell Lung Cancer
04/15/2005
PharmaFrontiers Provides Update, Financial Results
03/30/2005
Agennix Raises $22 Million in Private Financing
02/28/2005
Spectral Genomics, Inc. Names GE Healthcare as Its Exclusive International Distributor
02/14/2005
Kryptiq Corporation and GE Healthcare Sell ClinicalMessenger™ to Community Health Networks to Extend Reach of Electronic Medical Records
Kryptiq and GE Healthcare Provide Integrated Solution for Electronic Sharing of Patient Information Across Community Health Network and 500 Affiliated Physicians
02/14/2005
Kryptiq Clinical Messaging Integrated with Electronic Health Records Saves Healthcare Industry $10.37 per Referral
e-Referral Study Validates Business Case and Usability for Community Adoption of New Cost-Effective and Efficient Information Sharing Model
02/14/2005
Demand for EHR Connectivity in Community Settings Drives Growth of Kryptiq Corp.
Inland Northwest Health Services, Community Health Network, and Providence Health System Demonstrate Trend Toward Adoption of Clinical Messaging Technologies
02/14/2005
Kryptiq Introduces Disease Management Product Developed for Providers
MedStar Health Adopts CareManager™ to Leverage Existing Medical Record Data to Improve Care for Patients with Chronic Illnesses
02/08/2005
Methylgene and EnVivo sign HDAC Collaboration Agreement
01/19/2005
Kryptiq Aligns with Newt Gingrich and The Center for Health Transformation
National Effort Will Help Realize Improved Healthcare for All Americans
01/10/2005
Rejuvenon’s RC-1291 Ghrelin Mimetic Receives Fast Track
Designation from FDA for Cancer Anorexia/Cachexia
12/09/2004
BCM Technologies names two new directors to the Board, James Hackett and Alan Buckwalter.
11/15/2004
Spectral Genomics, Inc. Announces
release of SpectralWare Web 2.2
11/15/2004
EnVivo Pharmaceuticals Secures $23 Million Series B Funding
09/29/2004
Kryptiq Signs Deal with Northwest Permanente to Automate Contract Management
09/28/2004
Fairway Medical Technologies, Inc. Expands Facilities
09/27/2004
MeritCare Takes First Step Towards Connected Health Network
Adoption of Clinical Messaging From Kryptiq Corp. Facilitates Adoption of National Health Information Infrastructure
08/30/2004
Fairway Medical Technologies receives a major grant to study breast cancer.
08/18/2004
Agennix Data Published in the International Journal of Cancer
08/16/2004
EnVivo Announces Hiring of Vice President of Chemistry
07/14/2004
EnVivo To Pay $1.1M For Licensing And Research Agreement With MethylGene
By John Galante
07/13/2004
MethylGene and EnVivo Pharmaceuticals to collaborate in Neurodegenerative Diseases
06/23/2004
Rejuvenon Raises $37 Million in Series B Venture Financing; New Board Members Named
06/09/2004
VAMC and Agennix Release Lactoferrin Cancer Trial Results at ASCO
05/25/2004
Agennix Receives SBIR Asthma Funding, Presents at ATS Meeting
05/03/2004
Industry Leaders Rally Around Connectivity Advancements in Healthcare
The 2004 Healthcare Connectivity Summit Unveils Roadmap for Better Care at Lower Costs Through Integration of Clinical Information Systems by 2010
04/19/2004
Kryptiq Sponsors First Annual Healthcare Connectivity Summit
Industry Leaders to Present Practical Strategies for Achieving Connectivity Among Healthcare Systems and Enabling Patient Data to be Securely Accessible to Involved Parties
03/31/2004
Medical Providers Across U.S. Adopt Secure Online Services from Kryptiq to Improve Access to Physicians
Kryptiq’s Integrated Web Portal Makes it Easier for Patients to Communicate With Physicians, Schedule Appointments, Access Personal Medical Information and More
03/30/2004
Agennix Presents Positive RhLF Cancer Results at AACR Meeting
03/22/2004
Kryptiq Joins AAFP Partners for Patients in EHR Movement
Kryptiq Joins American Academy of Family Physicians to
Enable Electronic Health Record Portability in Today’s Medical Practices
03/11/2004
InteGreat Offers Comprehensive Patient Portal Through Key Partnerships
03/10/2004
Spectral Genomics, Inc. Acquires Bacterial Barcodes, Inc.
Closes $9.3 Million Series B Financing
03/09/2004
Agennix Composition of Matter Patent on Recombinant Human Lactoferrin Upheld in Europe
02/23/2004
Kryptiq Introduces New Physician Office Web Portal
CareCatalyst™ Streamlines Patient/Clinic Communications and Integrates with Clinical Systems to Further Enable the Connected Medical Practice
02/23/2004
Kryptiq Unveils New Solution for Managing Healthcare Insurance Contracts
Kryptiq Guardian Contract Manager™ Provides End-to-End Solution
for Managing all Cycles of Payer-Provider Contracts
02/17/2004
Kryptiq to Demonstrate Technologies for Connecting Healthcare at HIMSS
Kryptiq Announces Support of CCR Initiative and Introduces New Solutions that Enable Information Portability, Accessibility and Clinical System Interoperability
02/04/2004
Kryptiq Selected by Eastern Maine Healthcare for Clinical Messaging and Systems Connectivity
Large East Coast Health System to Securely Connect Patients and Doctors Throughout Maine as Both a Customer and Reseller
01/26/2004
Kryptiq Suite of Products Selected by Capital Region Healthcare
Large New Hampshire Health System Will Connect Patients and Doctors Securely Using Kryptiq’s Clinical Messaging System and Web-based forms tool
01/19/2004
Kryptiq Corporation Acquires T.H.I.S. Computer Solution, Inc.
Kryptiq Provides Transparency to Contract Management for US Health Insurance Providers
12/05/2003
EnVivo Appoints Several Leaders to Its Scientific Advisory Board
12/03/2003
Austin Diagnostic Clinic Selects Kryptiq for Secure Messaging
One of Nation’s Largest Physician Owned Clinics Installs Secure Messaging to Improve Clinical Workflow and Quality of Care
11/17/2003
EnVivo Announces Key Additions to Its Management Team
11/10/2003
Kryptiq Corporation Acquires MedShape
Document Management Solutions and Interface Engine Technology From MedShape Expands Kryptiq's Existing Healthcare Workflow Messaging Platform
10/27/2003
EnVivo Pharmaceuticals Has Moved to Watertown, Massachusetts
10/20/2003
Spectral Genomics Forges License Agreement with Affymetrix
10/15/2003
New DNA Array at Spectral Genomics, Inc.
10/13/2003
The Heart Institute of Spokane Implements Kryptiq's Secure Messaging Solution for Communicating Confidential Health Information
Increased Workflow Efficiency, Improved Quality of Care and HIPAA Compliance Drive Adoption of Kryptiq Secure Email
10/01/2003
Brown names Swartley as the Senior Vice President of BCMT.
09/23/2003
Bacterial Barcodes to Incorporate Agilent Technologies 2100 Bioanalyzer as Part of Its DiversiLab System
09/17/2003
Agennix Inc. Receives $850,000 NIH Funding to Support Clinical Trials of rhLF Gel for Treatment of Patients with Diabetic Foot Ulcers
09/10/2003
Kryptiq Extends Leadership and Presence in National Healthcare Market
Leading Provider of Messaging-Based Workflow Solutions Attracts Industry Veterans
08/13/2003
Michigan State University Health Selects Kryptiq for Connecting Patient Health Data
Integrated Electronic Medical Record Solution Streamlines Healthcare Communications
08/11/2003
New CEO at Spectral Genomics, Inc.
08/04/2003
Spectral Genomics, Inc. Names Robert Johnson President and COO
07/30/2003
Kryptiq Corporation Releases E-Gateway
New Security and Workflow Solution Connects Critical Health Data Using Email
07/22/2003
Kryptiq Corporation Acquires RosettaMed
Company Adds Forms Capability to Automated Healthcare Workflows
07/18/2003
Brown is named president of BCM Technologies Inc.
07/16/2003
Stopping rogue infectious agents in the nick of time
07/08/2003
CareOregon Selects Kryptiq for HIPAA Compliance
06/30/2003
Agennix appoints Dr. Frank Young Chairman of its Board of Directors
06/18/2003
Agennix Inc. Presents Positive Results Showing Accelerated Wound Healing and Wound Closure with Topical Recombinant Human Lactoferrin
06/05/2003
BCMT/BioHouston Life Science Conference Summary
05/22/2003
VAMC and Agennix Successfully Complete Safety Phase of Lactoferrin Cancer Trial
04/30/2003
Kryptiq Joins GE Medical Systems Partner Program
New Solution Migrates Logician Users from Fax to Secure Email
04/23/2003
Legacy Health System Selects Kryptiq For Email Security
Increased Security of Patient Data at Largest Oregon-Based, Not-For-Profit Healthcare System
02/26/2003
BCM Technologies / BioHouston Life Science Conference
02/11/2003
Bacterial BarCodes closes $6 Million Series C Financing
01/16/2003
BCM Technologies Forms Venture Advisory Board
10/24/2002
wired.MD, Inc. and Kryptiq Corp. Combine Forces to Provide First Out-of-Office Interactive Patient Communication and Education Solution
Video Patient Education Software and HIPAA-Compliant Secure Email DeliverCustomized and Confidential Information to Patients with Internet Access
10/10/2002
Kryptiq Launches Secure Email Technology Targeting Health Care Organizations
Integrated Software Application Streamlines Business Processes and Facilitates HIPAA Compliance
10/03/2002
EnVivo Pharmaceuticals closes $14.7M Series A round led by Fidelity Biosciences Group - David A. Lowe, Ph.D. appointed as President and CEO
10/01/2002
EnVivo Awarded NIH Grant to Develop Technology for CNS Drug Discovery
09/30/2002
TIPAAA Selects Kryptiq as Partner to Provide Secure Messaging Solutions
Healthcare Community To Benefit From Streamlined Business Processes and HIPAA Compliance
09/17/2002
Agennix and DSM Pharmaceutical Products announce opening of recombinant human lactoferrin manufacturing facility
09/04/2002
Kryptiq Delivers Healthcare Productivity Through New Approach to Secure Email
Community of Healthcare Providers Connected through Improved Workflow Solutions
05/29/2002
Agennix Completes $20 Million Private Placement Financing
05/01/2002
Start-Up : In Focus : BCM Technologies, Inc.
05/14/2001
Dr. Waun Ki Hong, head of M.D. Anderson's Division of Cancer Medicine joins Agennix's Scientific Advisory Board
05/10/2001
Agennix Receives Broad Patent Covering Production of Human Lactoferrin in Eukaryotic Cells
|